This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

District Court Says Inmate's Claim Against Prison Operators May Proceed





LOS ANGELES, Feb. 22, 2013 /PRNewswire/ -- Asserting that their inmate-client, Gregory Edison, was negligently exposed to a terminal and deadly form of Valley Fever, Los Angeles-based attorneys, Jason Feldman and Ian Wallach, prevailed in court on Friday, February 22, 2013, when the court held that the case of Edison v. GEO Group, Inc. et a l. (EDCA 1:12-cv-02026) could proceed.

The case before the United States District Court for the Eastern District of California, brought by an inmate housed at the Taft Correctional Facility in Taft, California, alleges that the subcontractors who operated the prison, The GEO Group, Inc. ("GEO") and Management and Training Corporation ("MTC"), failed to protect Mr. Edison from acquiring the terminal form of coccidiodomycosis (aka "Valley Fever").  

GEO and MTC moved to dismiss the case--asserting that the Plaintiff failed to exhaust the administrative remedy filing requirements normally asserted by Governmental entities.  Feldman and Wallach countered that such requirements do not apply to tort claims against private entities.

United States Senior District Judge Anthony W. Ishii upheld the findings of Magistrate Judge Jennifer L. Thurston, who had explained that there was no statutory authority supporting Defendants' argument that they were permitted to impose an administrative remedy that must be exhausted before an inmate may file a complaint raising state tort claims. 

The Defendant corporations cited Wright v. State of California , 122 Cal.App.4th 659 (Cal.Ct.App. 2004), as authority for the proposition that an inmate raising a state-law claim must exhaust administrative remedies before suing them.  The Court disagreed, by stating "Neither GEO nor MTC are administrative tribunals. Thus, there is no other tribunal involved whose jurisdiction is an impediment to this Court's authority. Likewise, the instant matter does not concern remedies provided by an administrative agency, but instead, a remedial scheme imposed by private corporations." The Court further stated "There are statutorily-mandated procedures in place for tort claims (28 CFR part 543, subpart C) . . .. Coupled with 28 CFR § 542.10's explicit instruction that '…the Bureau will refer the inmate to the appropriate statutorily-mandated procedures,' there can be no serious argument that tort claims brought against the [Bureau of Prisons] must be pursued according to the four-part process as a prerequisite to filing suit."   The ruling also concluded its ruling remarks, with "Therefore, because 28 CFR § 542.10 does not require a federal prisoner placed in a federal prison to exhaust a tort claim through the four-part administrative remedy program, there is no legal footing for the proposition that a federal prisoner placed in a non-federal facility, must." 

"This is a great win for inmates whose terminal illnesses could have been prevented," said attorney Wallach, "All these prisoners want is their day in court. Wallach went on to say, "These rulings have paved the way for that possibility."    

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,051.73 -48.45 -0.28%
S&P 500 1,973.63 -4.59 -0.23%
NASDAQ 4,424.7040 -7.4420 -0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs